Could a cheap old drug beat blood cancer? lab study launches
NCT ID NCT04234022
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study takes blood or bone marrow samples from 70 adults with multiple myeloma or acute leukemia to test a drug called Imuthiol (Zn-DDC) in the lab. Researchers want to see if Imuthiol, alone or with other drugs, can kill cancer stem cells. This is not a treatment study—it's a first step to see if the drug is worth testing in future human trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Royal Wolverhampton NHS Trust
RECRUITINGWolverhampton, WV10 0QP, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact